This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Sanofi via Globenewswire
HUG#1871523

Print Friendly, PDF & Email

Sanofi : Lemtrada de Genzyme approuvé par la FDA

ACTUALITÉS ÉCONOMIQUES ET FINANCIÈRES |